These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17493)

  • 1. Interaction of calcium ions with serum albumin in chronic renal failure.
    Leme CE; Silva HB
    Clin Chim Acta; 1977 Jun; 77(3):287-94. PubMed ID: 17493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolism of human serum albumin in renal failure on conservative and dialysis therapy.
    Bianchi R; Mariani G; Toni MG; Carmassi F
    Am J Clin Nutr; 1978 Sep; 31(9):1615-26. PubMed ID: 685877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biophysical studies on the correction of uremic human serum albumin binding defects by in vitro charcoal adsorption treatment.
    Nikolaev V; Sarnatskaya V; von Appen K; Ivanov A; Rotellar E; Haspar M; Klinkmann H
    Artif Organs; 1996 Jan; 20(1):17-23. PubMed ID: 8645124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of plasma albumin in relation to decreased drug binding in uremia.
    Boobis SW
    Clin Pharmacol Ther; 1977 Aug; 22(2):147-53. PubMed ID: 407044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum uremic toxins from patients with chronic renal failure displace the binding of L-tryptophan to human serum albumin.
    Mingrone G; De Smet R; Greco AV; Bertuzzi A; Gandolfi A; Ringoir S; Vanholder R
    Clin Chim Acta; 1997 Apr; 260(1):27-34. PubMed ID: 9101098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortisol binding in uremic plasma. II. Decreased cortisol binding to albumin.
    Rosman PM; Benn R; Kay M; Wallace EZ
    Nephron; 1984; 37(4):229-31. PubMed ID: 6462312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deranged platelet calcium homeostasis in diabetic patients with end-stage renal failure. A possible link to increased cardiovascular mortality?
    Vicari AM; Taglietti MV; Pellegatta F; Spotti D; Melandri M; Galli L; Ronchi P; Folli F
    Diabetes Care; 1996 Oct; 19(10):1062-6. PubMed ID: 8886550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between serum calcium concentration and glucose tolerance in normal and azotaemic patients.
    Lisch HJ; Bolzano K; Patsch J; Sailer S; Braunsteiner H
    Diabetologia; 1973 Dec; 9(6):467-71. PubMed ID: 4204179
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased bilirubin-binding capacity in uremic serum caused by an accumulation of furan dicarboxylic acid.
    Tsutsumi Y; Maruyama T; Takadate A; Shimada H; Otagiri M
    Nephron; 2000 May; 85(1):60-4. PubMed ID: 10773757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 25-hydroxycholecalciferol in Greek uremics.
    Drivas G; Bamias J; Tsomis A; Kalos A; Douratsos D; Melissinos K
    Invest Urol; 1980 Jul; 18(1):52-3. PubMed ID: 7410014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin III in uremia.
    Jørgensen KA; Stoffersen E
    Scand J Urol Nephrol; 1979; 13(3):299-303. PubMed ID: 531528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding of chloramphenicol to albumin of normal and uremic sera.
    Vodrázka Z; Jandová D; Grafnetterová J; Schück O; Kalousek I; Tomaásek R; Lachmanová J
    Biochem Pharmacol; 1978; 27(13):1717-20. PubMed ID: 708450
    [No Abstract]   [Full Text] [Related]  

  • 14. Albumin-corrected or ionized calcium in renal failure? What to measure?
    Gøransson LG; Skadberg Ø; Bergrem H
    Nephrol Dial Transplant; 2005 Oct; 20(10):2126-9. PubMed ID: 16030044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure.
    Olsen GD; Bennett WM; Porter GA
    Clin Pharmacol Ther; 1975 Jun; 17(6):677-84. PubMed ID: 1095281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
    Lu KC; Lin SH; Yu FC; Chyr SH; Shieh SD
    Miner Electrolyte Metab; 1995; 21(6):398-402. PubMed ID: 8592483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pH and NaCl on measurements of ionized calcium in matrices of serum and human albumin with a new calcium-selective electrode.
    Rehfeld SJ; Barkeley J; Loken HF
    Clin Chem; 1984 Feb; 30(2):304-7. PubMed ID: 6692542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma protein carbonylation in chronic uremia.
    Pavone B; Sirolli V; Giardinelli A; Bucci S; Forlì F; Di Cesare M; Sacchetta P; Di Pietro N; Pandolfi A; Urbani A; Bonomini M
    J Nephrol; 2011; 24(4):453-64. PubMed ID: 21607919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of calcitriol on fasting urine calcium loss and renal tubular reabsorption of calcium in patients with mild renal failure--actions of a permissive hormone.
    Cochran M; Coates PT; Morris HA
    Clin Nephrol; 2005 Aug; 64(2):98-102. PubMed ID: 16114785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric monitoring of albumin in uremia.
    Thornalley PJ; Argirova M; Ahmed N; Mann VM; Argirov O; Dawnay A
    Kidney Int; 2000 Nov; 58(5):2228-34. PubMed ID: 11044246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.